DMP.XETRA Dermapharm Holding SE

Healthcare Pharmaceuticals XETRA Stock Exchange
38.50 EUR
Close of Nov 5, 2026
32.39 50.94
Market cap
EUR 1.91B
P/E
13.9x
P/B
3.55x
ROE
25.5%
Dividend yield
2.54%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is DMP.XETRA undervalued?

Graham number
Price38.50
Graham value26.00
Premium48.1%

DMP.XETRA trades 48.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dermapharm Holding SE fundamental analysis

No fundamental analysis for Dermapharm Holding SE yet.

Dermapharm Holding SE stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal e…

Full company profile